SCHEMBL1701138

SCHEMBL1701138

O=CC(Br)c1ccc(F)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 3/20 0.40
SLC6A2 P23975 3/20 0.39
SLC6A4 P31645 3/20 0.39
SLC6A3 Q01959 3/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
KCNH2 Q12809 1/20 0.39
ERCC1 P07992 1/20 0.37
ERCC4 Q92889 1/20 0.37
PTGS2 P35354 4/20 0.34
PTGS1 P23219 2/20 0.34
SLC2A1 P11166 1/20 0.34
RPA1 P27694 1/20 0.34
SCN8A Q9UQD0 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20722071 0.85 PSEN1 (0.35) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL3973135 0.85 PSEN1 (0.35) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL747175 0.82 ALDH1A1 (0.43) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL21495095 0.82 ALDH1A1 (0.43) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL998053 0.82 CES2 (0.42)
SCHEMBL6865041 0.79 VCP (0.38)
SCHEMBL12615184 0.79 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL3875292 0.78 SLC6A2 (0.44) MDM2SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL9865420 0.78 PTGS2 (0.41) MDM2SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL8149369 0.78 MDM2 (0.43) MDM2SLC6A2SLC6A4SLC6A3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585459-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF Chiesi Farmaceutici S.p.A. (IT) 2013-05-01 EP disclosed
EP-2467381-A1 SUBSTITUTED (THIAZOLYL-CARBONYL)IMIDAZOLIDINONES AND USE THEREOF FOR TREATING RETROVIRAL DISEASES AiCuris GmbH & Co. KG (DE) 2012-06-27 EP disclosed
WO-2011161018-A1 ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF CHIESI FARMACEUTICI S.P.A. (IT) 2011-12-29 WO disclosed
EP-2376490-A1 IMIDAZOPYRIDINE COMPOUNDS Proximagen Limited (GB) 2011-10-19 EP disclosed
EP-2323978-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-05-25 EP disclosed
WO-2011020822-A1 SUBSTITUTED (THIAZOLYL-CARBONYL)IMIDAZOLIDINONES AND USE THEREOF FOR TREATING RETROVIRAL DISEASES AICURIS GMBH & CO. KG (DE) 2011-02-24 WO disclosed
EP-2265606-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2010-12-29 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed
WO-2010018874-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-02-18 WO disclosed
WO-2009129109-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-10-22 WO disclosed